SCHEMBL21600993

SCHEMBL21600993

C=CC(=O)Nc1cc(N2CCC(N3CCOCC3)CC2)c(Cl)cc1Nc1ncc(C#N)c(-c2c[nH]c3ccccc23)n1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 12/20 0.54
▸ CDK7 P50613 8/20 0.47
▸ CCNH P51946 8/20 0.47
▸ MNAT1 P51948 7/20 0.47
▸ CDK1 P06493 1/20 0.47
▸ CCNB1 P14635 1/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ CCNT1 O60563 6/20 0.47
▸ CDK9 P50750 6/20 0.47
▸ CCNA2 P20248 5/20 0.47
▸ CDK2 P24941 5/20 0.47
▸ IGF1R P08069 2/20 0.45
▸ KCNH2 Q12809 2/20 0.45
▸ CCNK O75909 1/20 0.42
▸ CDK13 Q14004 1/20 0.42
▸ CDK12 Q9NYV4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21600990 0.88 EGFR (0.57) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21601034 0.87 CDK7 (0.54) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600996 0.86 CDK7 (0.53) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600999 0.84 CDK7 (0.56) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21601001 0.83 CDK7 (0.55) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600992 0.81 EGFR (0.53) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600994 0.81 CDK7 (0.54) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600997 0.81 CDK7 (0.44) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21601031 0.80 EGFR (0.62) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21601000 0.78 EGFR (0.54) EGFRCDK7CCNHMNAT1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019242689-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2019-12-26 — — WO disclosed
Send feedback